Zobrazeno 1 - 10
of 77 648
pro vyhledávání: '"DRUG APPROVAL"'
Autor:
Rim MH; Northwestern Medicine, Chicago, IL, USA., Dean C; Northwestern Medicine, Chicago, IL, USA., Aliaj E; Northwestern Medicine, Chicago, IL, USA., Karas BL; Northwestern Medicine, Chicago, IL, USA., Barada F; Northwestern Medicine, Chicago, IL, USA., Levitsky AM; IPD Analytics, Aventura, FL, USA.
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Nov 07; Vol. 81 (22), pp. 1103-1108.
Autor:
Manski CF; Department of Economics and Institute for Policy Research, Northwestern University, Evanston, IL, USA. Electronic address: cfmanski@northwestern.edu.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Dec; Vol. 27 (12), pp. 1637-1640. Date of Electronic Publication: 2024 Mar 26.
Autor:
Martínez-Barros H; Servicio de Farmacia, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, España. Electronic address: hilario.martinez@salud.madrid.org., Pousada-Fonseca Á; Servicio de Farmacia, Hospital Universitario de Móstoles, Madrid, España., Pedreira-Bouzas J; Servicio de Farmacia, Hospital Universitario de Fuenlabrada, Madrid, España., Clopés-Estela A; Servicio de Farmacia, Instituto Catalán de Oncología (ICO), Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universidad Ramon Llull, Barcelona, España.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Nov-Dec; Vol. 48 (6), pp. 272-277. Date of Electronic Publication: 2024 May 25.
Autor:
Martínez-Barros H; Servicio de Farmacia, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Electronic address: hilario.martinez@salud.madrid.org., Pousada-Fonseca Á; Servicio de Farmacia, Hospital Universitario de Móstoles, Madrid, Spain., Pedreira-Bouzas J; Servicio de Farmacia, Hospital Universitario de Fuenlabrada, Madrid, Spain., Clopés-Estela A; Servicio de Farmacia, Instituto Catalán de Oncología (ICO) t, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), Universidad Ramon Llull, Barcelona, Spain.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Nov-Dec; Vol. 48 (6), pp. T272-T277. Date of Electronic Publication: 2024 Jul 27.
Autor:
Mangia F; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland. francesca.mangia@roche.com., Lin YM; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Armando J; Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Dominguez K; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Rozhnova V; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland., Ausborn S; F.Hoffmann-La Roche, Grenzacherstrasse 124, Basel, 4058, Switzerland.
Publikováno v:
Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2024 Nov; Vol. 58 (6), pp. 997-1005. Date of Electronic Publication: 2024 Jul 24.
Autor:
Khanani I; Duke University, Durham, NC., Aziz AA; University of Nevada, Reno School of Medicine, Reno, NV., Khanani ZA; Sierra Eye Associates, Reno, NV., Khan H; University of Nevada, Reno School of Medicine, Reno, NV., Mojumder O; Sierra Eye Associates, Reno, NV., Sulahria H; Sierra Eye Associates, Reno, NV., Ali H; Sierra Eye Associates, Reno, NV.; University of Nevada, Reno, Reno, NV., Khan H; Sierra Eye Associates, Reno, NV., Rahimzadeh TS; Sierra Eye Associates, Reno, NV., Vannavong J; Sierra Eye Associates, Reno, NV., Gahn GM; University of Nevada, Reno School of Medicine, Reno, NV.; Sierra Eye Associates, Reno, NV., Khanani AM; University of Nevada, Reno School of Medicine, Reno, NV.; Sierra Eye Associates, Reno, NV.
Publikováno v:
International ophthalmology clinics [Int Ophthalmol Clin] 2025 Jan 01; Vol. 65 (1), pp. 3-7. Date of Electronic Publication: 2024 Dec 23.
Autor:
Chaugule PD; Department of Regulatory Affairs, National Institute of Pharmaceutical Education and Research-Hyderabad, Balanagar, Hyderabad, Telangana 500037, India., Varpe PC; Department of Regulatory Affairs, National Institute of Pharmaceutical Education and Research-Hyderabad, Balanagar, Hyderabad, Telangana 500037, India., Tandulje AA; Department of Regulatory Affairs, National Institute of Pharmaceutical Education and Research-Hyderabad, Balanagar, Hyderabad, Telangana 500037, India., Raghuvanshi RS; Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, New Delhi, India., Srivastava S; Department of Regulatory Affairs, National Institute of Pharmaceutical Education and Research-Hyderabad, Balanagar, Hyderabad, Telangana 500037, India; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Electronic address: saurabh@niperhyd.ac.in.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2025 Jan; Vol. 205, pp. 104539. Date of Electronic Publication: 2024 Nov 08.
Autor:
Kobayashi M; Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.; Pfizer R&D Japan, Tokyo, Japan., Narukawa M; Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 270-277. Date of Electronic Publication: 2024 Oct 02.
Autor:
Matsuda K; Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.; Department of Hematology and Oncology, JR Tokyo General Hospital, Tokyo, Japan., Nagai S; Department of Medical Development, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Tokyo, Japan., Sugimoto K; Department of Hematology and Oncology, JR Tokyo General Hospital, Tokyo, Japan.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 232-239. Date of Electronic Publication: 2024 Sep 10.
Autor:
Mandslay D; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal., Almeida D; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal., Marques A; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal., Rocha J; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal., Drafi F; Centre of Experimental Medicine SAS, Institute of Experimental Pharmacology and Toxicology, Bratislava, Slovakia.; State Institute for Drug Control, Bratislava 26, Slovakia., Sepodes B; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal., Torre C; Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal.; Laboratory of Systems Integration Pharmacology, Clinical and Regulatory Science, Research Institute for Medicines of the University of Lisbon (iMED.ULisboa), Lisbon, Portugal.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2025 Jan; Vol. 117 (1), pp. 73-93. Date of Electronic Publication: 2024 Aug 14.